The burden of malaria in pregnancy in malaria-endemic areas

American Journal of Tropical Medicine and Hygiene

Volumn 64, Issue 1-2 SUPPL., 2001, Pages 28-35

  Steketee, R W ^a   Nahlen, B L ^a   Parise, M E ^a   Menendez, C ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; CHILD DEATH; CONFERENCE PAPER; CONGENITAL INFECTION; DISEASE ASSOCIATION; DISEASE TRANSMISSION; ENDEMIC DISEASE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT MORTALITY; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MALARIA; PREGNANCY; PREMATURITY; RISK FACTOR;

HUMAN IMMUNODEFICIENCY VIRUS; PROTOZOA;

EID: 0034967221     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2001.64.28     Document Type: Conference Paper

References (70)

1. The influence of malarial infection of the placenta on the incidence of prematurity
2. Malaria and prematurity in the western region of Nigeria
3. Malaria infection of the placenta and its influence on the incidence of prematurity in eastern Nigeria
4. Low birth weight and malaria infection of the placenta
5. Malaria at delivery in Abidjan
6. Malaria, anaemia, and pregnancy
7. Epidemiology, malaria and pregnancy
8. An analysis of malaria in pregnancy in Africa
9. WHO expert committee on malaria 18th report
10. Malaria is an important cause of anaemia in primigravidae: Evidence from a district hospital in coastal Kenya
11. Effect of chloroquine prophylaxis during pregnancy on maternal haematocrit
12. Malaria infection of the placenta in The Gambia, West Africa: Its incidence and relationship to stillbirth, birth weight, and placental weight
13. The effect of malaria and malaria prevention in pregnancy on offspring birth weight, prematurity, and intrauterine growth retardation in rural Malawi
14. Malaria in pregnancy in an area of unstable endemicity
15. Malaria infection during pregnancy: Intrauterine growth retardation and preterm delivery in Malawi
16. Determinants of low birth weight: Methodological assessment and meta-analysis
17. The contribution of low birth weight to infant mortality and childhood mortality
18. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1
19. Developing effective strategies for malaria prevention programs for pregnant African women
20. Malaria chemoprophylaxis, birth weight and child survival
21. Estimating population attributable risk from multiple risk factors using case-control data
22. Increase of birth weight following chloroquine chemoprophylaxis during the first pregnancy: Results of a randomized trial in Cameroon
23. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control
24. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birth weight in rural Malawi
25. Effect of chloroquine chemoprophylaxis during pregnancy on birth weight: Results of a randomized trial
26. Consequences of maternal anemia on outcome of pregnancy in a malaria endemic area in Papua New Guinea
27. Mefloquine prophylaxis prevents malaria during pregnancy: A double-blind placebo-controlled study
28. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection
29. Human immunodeficiency virus infection and malaria as risk factors for third trimester anemia in asymptomatic pregnant Kenyan women
30. Rates and risk factors for mortality during the first two years of life in rural Malawi
31. Evaluation of maternal practices and efficacy of alternative antimalarial regimens for use in pregnancy: Chloroquine and sulfadoxine-pyrimethamine
32. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi
33. Intermittent sulphadoxine-pyrimethamine in pregnancy: Effectiveness against malaria morbidity in Blantyre, Malawi, 1997-1999
34. Malaria chemosuppression in pregnancy. II: Its effect on maternal haemoglobin levels, placental malaria and low birth weight
35. The impact of a national impregnated bed net programme on the outcome of pregnancy in primigravidae in The Gambia
36. Permethrin-treated bednets reduce malaria in pregnancy in an area of intense perennial malaria transmission in western Kenya
37. Maternal and fetal characteristics in an obstetric cohort in Mozambique
38. Malarial infection and birthweight in urban Zanzibar, Tanzania
39. Anaemia in pregnancy: Plasmodium falciparum infection is an important cause in primigravidae in Hoima district, western Uganda
40. Bed nets for the prevention of malaria and anaemia in pregnancy
41. The impact of placental malaria on gestational age and birthweight
42. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: A randomized placebo-controlled trial
43. Anaemia- and malaria-attributable low birth weight in two populations in Papua New Guinea
44. Malaria in pregnancy and its consequences for the infant in rural Malawi
45. An analysis of the determinants of anaemia in pregnant women in rural Malawi - A basis for action
46. A community randomized controlled trial of insecticide-treated bednets for the prevention of malaria and anaemia among primigravid women on the Kenyan coast
47. The epidemiology and burden of Plasmodium falciparum malaria-related anemia among pregnant women in sub-Saharan Africa
48. Seasonality, malaria, and the impact of prophylaxis in a West African village. 1: Effect of anemia in pregnancy
49. Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life
50. Risk factors for anemia in young children in Malawi
51. HIV and malaria overlap and do interact in sub-Saharan African pregnant women
52. Pathophysiology and management of HIV-associated hematologic disorders
53. Maternal HIV infection and infant mortality in Malawi: Evidence for increased mortality due to placental malaria infection
54. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomised trial
55. 6-Month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: A double-blind, placebo-controlled multicentre trial
56. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial
57. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
58. Evaluation of maternal practices, efficacy, and cost-effectiveness of alternative antimalarial regimens for use in pregnancy: Chloroquine and sulfadoxine-pyrimethamine
59. The cost-effectiveness of a single dose nevirapine regimen to mother and infant to reduce vertical HIV transmission in Uganda
60. Improving antenatal care for pregnant adolescents in southern Malawi
61. A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas
62. Seasonality, malaria, and the impact of prophylaxis in a West African village. II: Effect on birthweight
63. Gestational malaria: Assessment of its consequences on fetal growth
64. Placental Plasmodium falciparum in East Sepik (Papua New Guinea) women of different parity: The apparent absence of acute effects on mother and foetus
65. The prevention of anaemia in pregnancy in primigravidae in guinea savanna of Nigeria